Posted on: 16 December, 2024
Two emerging leaders within the Kolling Institute’s Ageing and Pharmacology Lab are gaining attention for their impressive work to improve the quality use of medications.
Dr Nashwa Masnoon and Dr Kenji Fujita have received prestigious awards at the annual meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT).
Nashwa, who is also a pharmacist at .....
Read more
Category: Awards, Neuroscience and Pain Research, Research Excellence
Posted on: 11 December, 2024
An exciting partnership between AGRF Ltd (Australian Genome Research Facility) and the University of Sydney and the Kolling Institute will help strengthen genomic capabilities.
The partnership will see a specialised team and cutting-edge technology located within the institute to progress research in this increasingly crucial field.
As Australia’s largest provider of genomic services, AGRF supports.....
Read more
Category: New Treatment, Research Excellence
Posted on: 09 December, 2024
The Kolling Institute’s Professor Sue Kurrle and her team at the Rehabilitation and Aged Care Network at Hornsby Ku-ring-gai Hospital have been running clinical trials for 25 years, looking at dementia, frailty, and falls to name just some areas.
“We do trials as it keeps you cutting edge and they are really important for our patients,” she says.
As a geriatrician on the frontline, Sue is well posi.....
Read more
Category: Neuroscience and Pain Research, New Treatment, Research Excellence
Posted on: 20 November, 2024
A $3-million research grant will help develop technology to identify frailty in older people in hospital, a crucial step towards improving care and long-term patient outcomes.
The Kolling Institute’s Professor Sarah Hilmer will lead the large-scale study involving hospitals and universities across Australia as well as international investigators.
Professor Hilmer said the five-year project will dev.....
Read more
Category: Funding support, Research Excellence
Posted on: 15 November, 2024
We would like to thank everyone involved in the 2024 Kolling Institute Symposium.
During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop a unique wellbeing index.
Researche.....
Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Presentations, Research Excellence
Posted on: 12 November, 2024
Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There's a focus too on the first steps towards gene therapy for Meniere's disease, the latest research into treatments for dementia and.....
Read more
Category: New Treatment, Newsletters, Research Excellence
Posted on: 03 October, 2024
In the heart of the Kolling Institute, a world-renowned research centre, a raft of clinical trials is driving the future of healthcare.
“Clinical trials are intrinsic to research,” says Professor James Elliott, Academic Director of the institute. “They help us test something so that we can better inform care for patients with various conditions who come to our hospitals for treatment.”
The Kolling .....
Read more
Category: Research Excellence
Posted on: 15 August, 2024
Our researchers at the Kolling Institute are at the forefront of Meniere’s disease science developing the first humanised model of the disease ahead of gene therapy.
The specialised team is led by world-leading Meniere’s disease researcher and neuroscientist Professor Jose Antonio Lopez-Escamez who relocated from Spain to the institute to pursue his ground-breaking work.
His talented team of seven .....
Read more
Category: Neuroscience and Pain Research, Research Excellence, World-leading technology
Posted on: 07 August, 2024
Our Kolling Institute Year in Review profiles our innovative and life-changing research across the Kolling Institute.
Our researchers are driving investigations into some of the most challenging health conditions from heart and kidney disease to musculoskeletal conditions, chronic pain, cancer and neurodegenerative disorders.
Our teams have continued to increase their research impact, while forging.....
Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence
Posted on: 31 July, 2024
A team of researchers from the Kolling Institute’s John Walsh Centre for Rehabilitation Research has launched a study to develop the first internationally accepted guidelines for assessing cognitive function after a spinal cord injury.
The latest data indicates that over 15 million people globally live with a spinal cord injury, and in Australia, there are over 20,000 people living with the injury......
Read more
Category: Neuroscience and Pain Research, Research Excellence